Lv3
262 积分 2025-01-02 加入
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
14天前
已完结
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
14天前
已完结
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
14天前
已完结
Colorectal cancer
1个月前
已完结
Adrenocorticotropic hormone controls Concanavalin A activation of rat lymphocytes by modulating IL-2 production
1个月前
已完结
Free-Fatty Acid Receptor-4 (FFA4/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells
2个月前
已完结
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
2个月前
已完结
Gastric cancer
2个月前
已完结
皖公网安备34019202002308
